David Charles Lubner Insider Trading $TTPH TETRAPHASE PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for David Charles Lubner.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of David Charles Lubner. David Charles Lubner is SVP and CFO in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and EVP & CFO in Ra Pharmaceuticals, Inc. ($RARX) and Executive V.P. & CFO in Ra Pharmaceuticals, Inc. ($RARX) and Executive VP and CFO in Ra Pharmaceuticals, Inc. ($RARX) and Director in Nightstar Therapeutics plc ($NITE) and Director in Vor Biopharma Inc. ($VOR) and Director in Gemini Therapeutics, Inc. /DE ($FSDC) and Director in Dyne Therapeutics, Inc. ($DYN).

David Charles Lubner in TETRAPHASE PHARMACEUTICALS INC

Trading Symbol: TTPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Charles Lubner: SVP and CFO
Holdings: 69,270 shares
Current Value: $289,549
Latest Transaction: Aug 17 2015
$TTPH Market Capitalization: $155.73M
$TTPH Previous Close: $4.18

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of David Charles Lubner in TETRAPHASE PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, DYN, FSDC, NITE, RARX, TTPH, VOR

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 17 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseM7.949,50075,430123,799
Aug 17 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOSellS42.929,500407,74069,27078.8 K to 69.3 K (-12.06 %)
Aug 17 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOBuyM7.949,50075,43078,77069.3 K to 78.8 K (+13.71 %)
Jul 15 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseM7.941,70113,506133,299
Jul 15 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseM2.035,79911,77213,744
Jul 15 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOSellS48.927,500366,90069,27076.8 K to 69.3 K (-9.77 %)
Jul 15 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOBuyM7.941,70113,50676,77075.1 K to 76.8 K (+2.27 %)
Jul 15 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOBuyM2.035,79911,77275,06969.3 K to 75.1 K (+8.37 %)
Jun 16 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseM2.037,50015,22519,543
Jun 16 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOSellS41.677,500312,52569,27076.8 K to 69.3 K (-9.77 %)
Jun 16 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOBuyM2.037,50015,22576,77069.3 K to 76.8 K (+10.83 %)
Jun 16 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOSellS41.2910,000412,90069,27079.3 K to 69.3 K (-12.62 %)
May 18 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseM2.037,31614,85127,043
May 18 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseM2.037,68415,5990
May 18 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOSellS39.287,316287,37279,27086.6 K to 79.3 K (-8.45 %)
May 18 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOBuyM2.037,31614,85186,58679.3 K to 86.6 K (+9.23 %)
May 18 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOSellS39.287,684301,82879,27087 K to 79.3 K (-8.84 %)
May 18 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOBuyM2.037,68415,59986,95479.3 K to 87 K (+9.69 %)
Jan 09 2015TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseA39.94100,0003,994,000100,000
Jun 18 2014TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOSellS12.5113,530169,26078,46392 K to 78.5 K (-14.71 %)
Mar 10 2014TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOSellS13.654,51061,56291,99396.5 K to 92 K (-4.67 %)
Feb 13 2014TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOSellS13.924,50662,72496,503101 K to 96.5 K (-4.46 %)
Feb 11 2014TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseM2.0320,61441,84634,359
Feb 11 2014TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseM2.0333,29567,5897,684
Feb 11 2014TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseM0.8734,48229,9990
Feb 11 2014TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOSellS14.229,928141,176101,009110.9 K to 101 K (-8.95 %)
Feb 11 2014TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOBuyM2.0320,61441,846110,93790.3 K to 110.9 K (+22.82 %)
Feb 11 2014TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOBuyM2.0333,29567,58990,32357 K to 90.3 K (+58.38 %)
Feb 11 2014TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOBuyM0.8734,48229,99957,02822.5 K to 57 K (+152.94 %)
Jan 10 2014TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseA14.99100,0001,499,000100,000
May 17 2013TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseA7.94135,0001,071,900135,000
Mar 27 2013TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseC0.00116,68600
Mar 27 2013TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseC0.00115,00000
Mar 27 2013TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseC0.0052,17300
Mar 27 2013TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOOption ExerciseC0.0040,00000
Mar 27 2013TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOBuyC0.004,023022,54618.5 K to 22.5 K (+21.72 %)
Mar 27 2013TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOBuyC0.003,096018,52315.4 K to 18.5 K (+20.07 %)
Mar 27 2013TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOBuyC0.001,799014,55712.8 K to 14.6 K (+14.10 %)
Mar 27 2013TTPHTETRAPHASE PHARMAC ...Lubner David CharlesSVP and CFOBuyC0.001,379012,75811.4 K to 12.8 K (+12.12 %)

Page:   1

Contact us | Follow us on Twitter